Variant report
Variant | esv3349883 |
---|---|
Chromosome Location | chr13:65432000-65459575 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570352545 | chr13:65432412-65432413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs529643831 | chr13:65432427-65432428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs571170226 | chr13:65432496-65432497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs145179014 | chr13:65432532-65432533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs193052191 | chr13:65432607-65432608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs111518366 | chr13:65432651-65432652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs534112931 | chr13:65432690-65432691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs532085277 | chr13:65432691-65432692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs74690697 | chr13:65432715-65432716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570512804 | chr13:65432723-65432724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs539634914 | chr13:65432735-65432736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556156040 | chr13:65432747-65432748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs576263324 | chr13:65432756-65432757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs185663936 | chr13:65432789-65432790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs967958 | chr13:65432790-65432791 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs550532183 | chr13:65435013-65435014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185344052 | chr13:65435014-65435015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs542362984 | chr13:65435062-65435063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559078190 | chr13:65435065-65435066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs116195404 | chr13:65435068-65435069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs114853056 | chr13:65435089-65435090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs189709339 | chr13:65435098-65435099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs529710604 | chr13:65435099-65435100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs550978456 | chr13:65435103-65435104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs144271385 | chr13:65435154-65435155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs536739243 | chr13:65435189-65435190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs6562376 | chr13:65435190-65435191 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs183091874 | chr13:65435206-65435207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs150721647 | chr13:65435257-65435258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs79655105 | chr13:65435262-65435263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs559174387 | chr13:65435273-65435274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs575834683 | chr13:65435287-65435288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs544547070 | chr13:65435298-65435299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs35349751 | chr13:65435361-65435362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs556538411 | chr13:65435411-65435412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs112697418 | chr13:65435434-65435435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188175851 | chr13:65435490-65435491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs191715591 | chr13:65435493-65435494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528263465 | chr13:65435504-65435505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs544855263 | chr13:65435534-65435535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs183611315 | chr13:65435567-65435568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs373402133 | chr13:65435569-65435570 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs565121920 | chr13:65435613-65435614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs377412792 | chr13:65435650-65435651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs530704631 | chr13:65435659-65435660 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs375285047 | chr13:65435674-65435675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs567616827 | chr13:65435695-65435696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs530124513 | chr13:65435728-65435729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs547078965 | chr13:65435750-65435751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs187931314 | chr13:65435768-65435769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:65432400-65432800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
2 | chr13:65435000-65436400 | Enhancers | Liver | Liver |
3 | chr13:65440600-65441000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr13:65440600-65441000 | Enhancers | Fetal Stomach | stomach |
5 | chr13:65443400-65443800 | Enhancers | HUVEC | blood vessel |
6 | chr13:65443800-65445800 | Weak transcription | HUVEC | blood vessel |
7 | chr13:65445800-65446200 | Enhancers | HUVEC | blood vessel |
8 | chr13:65446200-65446400 | ZNF genes & repeats | Pancreas | Pancrea |
9 | chr13:65446200-65446600 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
10 | chr13:65446600-65451400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr13:65451400-65451600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |